Organon & Co. (OGN)
13.79
+0.05
(+0.36%)
USD |
NYSE |
Oct 07, 16:00
13.78
-0.01
(-0.07%)
Pre-Market: 20:00
Organon Shareholders Equity (Quarterly) : 1.006B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.006B |
| March 31, 2026 | 903.00M |
| December 31, 2025 | 752.00M |
| September 30, 2025 | 906.00M |
| June 30, 2025 | 733.00M |
| March 31, 2025 | 542.00M |
| December 31, 2024 | 472.00M |
| September 30, 2024 | 493.00M |
| June 30, 2024 | 144.00M |
| March 31, 2024 | 48.00M |
| December 31, 2023 | -70.00M |
| September 30, 2023 | -589.00M |
| Date | Value |
|---|---|
| June 30, 2023 | -555.00M |
| March 31, 2023 | -737.00M |
| December 31, 2022 | -892.00M |
| September 30, 2022 | -1.066B |
| June 30, 2022 | -1.137B |
| March 31, 2022 | -1.25B |
| December 31, 2021 | -1.508B |
| September 30, 2021 | -1.618B |
| June 30, 2021 | -1.934B |
| March 31, 2021 | 4.722B |
| December 31, 2020 | 5.486B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 41.93B |
| Pfizer Inc. | 85.19B |
| Bristol Myers Squibb Co. | 22.32B |
| Harmony Biosciences Holdings, Inc. | 999.24M |
| ANI Pharmaceuticals, Inc. | 597.21M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.18B |
| Total Liabilities (Quarterly) | 12.17B |
| Debt to Equity Ratio | 8.502 |
| Current Ratio | 1.954 |
| Net Debt Paydown Yield | 2.27% |